Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF

被引:31
|
作者
Ashrafi, M
Madani, T
Tehranian, AS
Malekzadeh, F
机构
[1] Royan Inst, Dept Endocrinol & Female Infertil, Tehran, Iran
[2] Iran Univ, Akbar Abadi Hosp, Med Sci & Hlth Serv, Tehran, Iran
[3] Azad Univ Islam Med Sci, Tehran, Iran
关键词
controlled ovarian hyperstimulation; follicle stimulating hormone level at day 3; oocyte; in vitro fertilization; poor ovarian response;
D O I
10.1016/j.ijgo.2005.06.017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the effect of basal follicle stimulating hormone (FHS) level on ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Methods: A descriptive and analytic study of 212 cycles of IVF chosen from about 2200 files of women treated at Royan Institute, Tehran, Iran, from 1991 to 1999. Treatment was started with intranasal or subcutaneous buserlin (0.5 cm(3)), on day 21 (long protocol). On day 2 of the next cycle, stimulation with human menopausal gonadotropin (hMG) was initiated. When the number and size of follicles were suitable, human chorionic gonadotropin (hCG) was given intramuscularly for ovulation induction, followed by oocyte retrieval 36 to 40 h later. Embryos were transferred about 48 to 72 h after oocyte retrieval. The women were assigned to 2 groups on the basis of day 3 serum FSH levels (>= 15 IU/mL, group 1 and < 15 IU/mL, group 2). Results: There were statistically significant differences between the 2 groups in number of follicles, number of oocytes retrieved and embryos transferred (lower in group 1), and level of serum luteinizing hormone and number of canceled cycles (higher in group 1). There were no statistical differences in number of ampoules of hMG used or age of patients. Conclusion: Day-3 serum FSH level was a predictor of ovarian response and IVF outcome in this study. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 50 条
  • [31] Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome
    d'Alva, CB
    Serafini, P
    Motta, E
    Kohek, MBD
    Latronico, AC
    Mendonca, BB
    FERTILITY AND STERILITY, 2005, 83 (06) : 1695 - 1699
  • [32] A comparison of 3-day and daily follicle-stimulating hormone injections on stimulation days 1-6 in women undergoing controlled ovarian hyperstimulation
    Scholtes, MCW
    Schnittert, B
    van Hoogstraten, D
    Verhoeven, HC
    Zrener, A
    Warne, DW
    FERTILITY AND STERILITY, 2004, 81 (04) : 996 - 1001
  • [33] Association of follicle stimulating hormone receptor promoter with ovarian response in IVF-ET patients
    Wang Dan
    Gao Jing
    Xia Liangbin
    Zhang Ting
    Zeng Ying
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2015, 13 (11) : 715 - 720
  • [34] A Randomized, Double-Blind, Multicenter Study Comparing a Starting Dose of 100 IU or 200 IU of Recombinant Follicle Stimulating Hormone (Puregon®) in Women Undergoing Controlled Ovarian Hyperstimulation for IVF Treatment
    Seang Lin Tan
    Timothy J. Child
    Anthony P. Cheung
    Margo R. Fluker
    Albert Yuzpe
    Robert Casper
    Peter Leung
    Kenneth Cadesky
    Victoria J. Davis
    Journal of Assisted Reproduction and Genetics, 2005, 22 : 81 - 88
  • [35] PREDICTION OF RESPONSE TO CONTROLLED OVARIAN HYPERSTIMULATION - A COMPARISON OF BASAL AND CLOMIPHENE CITRATE-STIMULATED FOLLICLE-STIMULATING-HORMONE LEVELS
    TANBO, T
    DALE, PO
    LUNDE, O
    NORMAN, N
    ABYHOLM, T
    FERTILITY AND STERILITY, 1992, 57 (04) : 819 - 824
  • [36] A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon®) in women undergoing controlled ovarian hyperstimulation for IVF treatment
    Tan, SL
    Child, TJ
    Cheung, AP
    Fluker, MR
    Yuzpe, A
    Casper, R
    Leung, P
    Cadesky, K
    Davis, VJ
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2005, 22 (02) : 81 - 88
  • [37] BASAL FOLLICLE-STIMULATING-HORMONE (FSH) PREDICTS RESPONSE TO CONTROLLED OVARIAN HYPERSTIMULATION (COH)-INTRAUTERINE INSEMINATION (IUI) THERAPY
    BURWINKEL, TH
    BUSTER, JE
    SCOGGAN, JL
    CARSON, SA
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1994, 11 (01) : 24 - 27
  • [38] Allergic reaction to a highly purified urinary follicle stimulating hormone preparation in controlled ovarian hyperstimulation for in vitro fertilization
    Battaglia, C
    Salvatori, M
    Regnani, G
    Primavera, MR
    Genazzani, AR
    Artini, PG
    Volpe, A
    GYNECOLOGICAL ENDOCRINOLOGY, 2000, 14 (03) : 158 - 161
  • [39] Effects of follicle stimulating hormone (FSH)-induced controlled ovarian hyperstimulation and nutrition on gene expression in ovine endometrium
    Bedir, O.
    Gram, A.
    Grazul-Bilska, A.
    Kowalewski, M. P.
    REPRODUCTION IN DOMESTIC ANIMALS, 2020, 55 : 4 - 5
  • [40] Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles
    van Wely, M
    Westergaard, LG
    Bossuyt, PMM
    van der Veen, F
    FERTILITY AND STERILITY, 2003, 80 (05) : 1121 - 1122